Impact of Multi-Morbidity and Polypharmacy on Health Outcomes in Older Age
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Geriatrics/Aging".
Deadline for manuscript submissions: closed (31 October 2019) | Viewed by 5460
Special Issue Editor
Interests: health services research; dementia; cardiovascular diseases; healthy ageing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Aging is associated with the accumulation of multiple chronic diseases and increased risk of varying degrees of physical, cognitive, and emotional impairment. Consequently, this multi-morbidity has led to polypharmacy, which is usually defined as taking five or more medications. Polypharmacy is associated with increased risk of drug interactions, adverse effects, and other side effects, such as falls in older people. Polypharmacy may also increase the risk of cognitive and physical impairment and frailty in elderly people, independent of other risk factors. Decline in cognitive, social, and emotional function frequently coexists with physical dysfunction in late life, and there may be common pathological pathways.
In this Special Issue, we are interested in receiving articles that will help us to better understand the impact of multi-morbidity and polypharmacy on physical, mental, and social outcomes, which are related to health and social care in older age. We welcome a wide range of research papers that provide epidemiological observations, trial evidence, and mechanistic links.
Prof. Dr. Phyo Myint
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Multi-Morbidity
- Polypharmacy
- Older Age
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
